0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pregabalin Capsule Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-26E12746
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Pregabalin Capsule Market Research Report 2023
BUY CHAPTERS

Global Pregabalin Capsule Market Research Report 2025

Code: QYRE-Auto-26E12746
Report
May 2025
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pregabalin Capsule Market

The global market for Pregabalin Capsule was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Pregabalin is an anticonvulsant drug used to treat neuropathic pain conditions and fibromyalgia, and for the treatment of partial onset seizures in combination with other anticonvulsants.
The global market may be influenced by the prevalence of conditions, as well as healthcare infrastructure and access to healthcare in different regions.The patent status of a drug can significantly influence market trends. If the patent has expired or is close to expiring, it can lead to the entry of generic versions, which can affect market dynamics, pricing, and competition.Market trends may be influenced by the approval of new indications or the expansion of the drug"s approved use. If new indications receives approval for additional medical conditions, it could potentially lead to increased sales and market growth.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pregabalin Capsule, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pregabalin Capsule.
The Pregabalin Capsule market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pregabalin Capsule market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pregabalin Capsule manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Pregabalin Capsule Market Report

Report Metric Details
Report Name Pregabalin Capsule Market
Segment by Type
  • 25mg Capsule
  • 50mg Capsule
  • 75mg Capsule
  • Others
Segment by Application
  • Clinics
  • Hospitals
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Actavis Pharma, Stat Rx USA, Accord Healthcare, Angita Pharma, Pfizer, Succeway Pharmaceuticals, Wan Vee Pharm, Qilu Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Pregabalin Capsule manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Pregabalin Capsule in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Pregabalin Capsule Market report?

Ans: The main players in the Pregabalin Capsule Market are Actavis Pharma, Stat Rx USA, Accord Healthcare, Angita Pharma, Pfizer, Succeway Pharmaceuticals, Wan Vee Pharm, Qilu Pharmaceutical

What are the Application segmentation covered in the Pregabalin Capsule Market report?

Ans: The Applications covered in the Pregabalin Capsule Market report are Clinics, Hospitals, Others

What are the Type segmentation covered in the Pregabalin Capsule Market report?

Ans: The Types covered in the Pregabalin Capsule Market report are 25mg Capsule, 50mg Capsule, 75mg Capsule, Others

1 Pregabalin Capsule Market Overview
1.1 Product Definition
1.2 Pregabalin Capsule by Type
1.2.1 Global Pregabalin Capsule Market Value Comparison by Type (2024 VS 2031)
1.2.2 25mg Capsule
1.2.3 50mg Capsule
1.2.4 75mg Capsule
1.2.5 Others
1.3 Pregabalin Capsule by Application
1.3.1 Global Pregabalin Capsule Market Value by Application (2024 VS 2031)
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Others
1.4 Global Pregabalin Capsule Market Size Estimates and Forecasts
1.4.1 Global Pregabalin Capsule Revenue 2020-2031
1.4.2 Global Pregabalin Capsule Sales 2020-2031
1.4.3 Global Pregabalin Capsule Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Pregabalin Capsule Market Competition by Manufacturers
2.1 Global Pregabalin Capsule Sales Market Share by Manufacturers (2020-2025)
2.2 Global Pregabalin Capsule Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Pregabalin Capsule Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Pregabalin Capsule, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pregabalin Capsule, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pregabalin Capsule, Product Type & Application
2.7 Global Key Manufacturers of Pregabalin Capsule, Date of Enter into This Industry
2.8 Global Pregabalin Capsule Market Competitive Situation and Trends
2.8.1 Global Pregabalin Capsule Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Pregabalin Capsule Players Market Share by Revenue
2.8.3 Global Pregabalin Capsule Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pregabalin Capsule Market Scenario by Region
3.1 Global Pregabalin Capsule Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Pregabalin Capsule Sales by Region: 2020-2031
3.2.1 Global Pregabalin Capsule Sales by Region: 2020-2025
3.2.2 Global Pregabalin Capsule Sales by Region: 2026-2031
3.3 Global Pregabalin Capsule Revenue by Region: 2020-2031
3.3.1 Global Pregabalin Capsule Revenue by Region: 2020-2025
3.3.2 Global Pregabalin Capsule Revenue by Region: 2026-2031
3.4 North America Pregabalin Capsule Market Facts & Figures by Country
3.4.1 North America Pregabalin Capsule Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Pregabalin Capsule Sales by Country (2020-2031)
3.4.3 North America Pregabalin Capsule Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pregabalin Capsule Market Facts & Figures by Country
3.5.1 Europe Pregabalin Capsule Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Pregabalin Capsule Sales by Country (2020-2031)
3.5.3 Europe Pregabalin Capsule Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pregabalin Capsule Market Facts & Figures by Region
3.6.1 Asia Pacific Pregabalin Capsule Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Pregabalin Capsule Sales by Region (2020-2031)
3.6.3 Asia Pacific Pregabalin Capsule Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pregabalin Capsule Market Facts & Figures by Country
3.7.1 Latin America Pregabalin Capsule Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Pregabalin Capsule Sales by Country (2020-2031)
3.7.3 Latin America Pregabalin Capsule Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pregabalin Capsule Market Facts & Figures by Country
3.8.1 Middle East and Africa Pregabalin Capsule Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Pregabalin Capsule Sales by Country (2020-2031)
3.8.3 Middle East and Africa Pregabalin Capsule Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pregabalin Capsule Sales by Type (2020-2031)
4.1.1 Global Pregabalin Capsule Sales by Type (2020-2025)
4.1.2 Global Pregabalin Capsule Sales by Type (2026-2031)
4.1.3 Global Pregabalin Capsule Sales Market Share by Type (2020-2031)
4.2 Global Pregabalin Capsule Revenue by Type (2020-2031)
4.2.1 Global Pregabalin Capsule Revenue by Type (2020-2025)
4.2.2 Global Pregabalin Capsule Revenue by Type (2026-2031)
4.2.3 Global Pregabalin Capsule Revenue Market Share by Type (2020-2031)
4.3 Global Pregabalin Capsule Price by Type (2020-2031)
5 Segment by Application
5.1 Global Pregabalin Capsule Sales by Application (2020-2031)
5.1.1 Global Pregabalin Capsule Sales by Application (2020-2025)
5.1.2 Global Pregabalin Capsule Sales by Application (2026-2031)
5.1.3 Global Pregabalin Capsule Sales Market Share by Application (2020-2031)
5.2 Global Pregabalin Capsule Revenue by Application (2020-2031)
5.2.1 Global Pregabalin Capsule Revenue by Application (2020-2025)
5.2.2 Global Pregabalin Capsule Revenue by Application (2026-2031)
5.2.3 Global Pregabalin Capsule Revenue Market Share by Application (2020-2031)
5.3 Global Pregabalin Capsule Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Actavis Pharma
6.1.1 Actavis Pharma Company Information
6.1.2 Actavis Pharma Description and Business Overview
6.1.3 Actavis Pharma Pregabalin Capsule Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Actavis Pharma Pregabalin Capsule Product Portfolio
6.1.5 Actavis Pharma Recent Developments/Updates
6.2 Stat Rx USA
6.2.1 Stat Rx USA Company Information
6.2.2 Stat Rx USA Description and Business Overview
6.2.3 Stat Rx USA Pregabalin Capsule Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Stat Rx USA Pregabalin Capsule Product Portfolio
6.2.5 Stat Rx USA Recent Developments/Updates
6.3 Accord Healthcare
6.3.1 Accord Healthcare Company Information
6.3.2 Accord Healthcare Description and Business Overview
6.3.3 Accord Healthcare Pregabalin Capsule Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Accord Healthcare Pregabalin Capsule Product Portfolio
6.3.5 Accord Healthcare Recent Developments/Updates
6.4 Angita Pharma
6.4.1 Angita Pharma Company Information
6.4.2 Angita Pharma Description and Business Overview
6.4.3 Angita Pharma Pregabalin Capsule Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Angita Pharma Pregabalin Capsule Product Portfolio
6.4.5 Angita Pharma Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Company Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Pregabalin Capsule Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Pfizer Pregabalin Capsule Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 Succeway Pharmaceuticals
6.6.1 Succeway Pharmaceuticals Company Information
6.6.2 Succeway Pharmaceuticals Description and Business Overview
6.6.3 Succeway Pharmaceuticals Pregabalin Capsule Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Succeway Pharmaceuticals Pregabalin Capsule Product Portfolio
6.6.5 Succeway Pharmaceuticals Recent Developments/Updates
6.7 Wan Vee Pharm
6.7.1 Wan Vee Pharm Company Information
6.7.2 Wan Vee Pharm Description and Business Overview
6.7.3 Wan Vee Pharm Pregabalin Capsule Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Wan Vee Pharm Pregabalin Capsule Product Portfolio
6.7.5 Wan Vee Pharm Recent Developments/Updates
6.8 Qilu Pharmaceutical
6.8.1 Qilu Pharmaceutical Company Information
6.8.2 Qilu Pharmaceutical Description and Business Overview
6.8.3 Qilu Pharmaceutical Pregabalin Capsule Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Qilu Pharmaceutical Pregabalin Capsule Product Portfolio
6.8.5 Qilu Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pregabalin Capsule Industry Chain Analysis
7.2 Pregabalin Capsule Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pregabalin Capsule Production Mode & Process Analysis
7.4 Pregabalin Capsule Sales and Marketing
7.4.1 Pregabalin Capsule Sales Channels
7.4.2 Pregabalin Capsule Distributors
7.5 Pregabalin Capsule Customer Analysis
8 Pregabalin Capsule Market Dynamics
8.1 Pregabalin Capsule Industry Trends
8.2 Pregabalin Capsule Market Drivers
8.3 Pregabalin Capsule Market Challenges
8.4 Pregabalin Capsule Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Pregabalin Capsule Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Pregabalin Capsule Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Pregabalin Capsule Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Pregabalin Capsule Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Pregabalin Capsule Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Pregabalin Capsule Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Pregabalin Capsule Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Pregabalin Capsule Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Pregabalin Capsule, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Pregabalin Capsule, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Pregabalin Capsule, Product Type & Application
 Table 12. Global Key Manufacturers of Pregabalin Capsule, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Pregabalin Capsule by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pregabalin Capsule as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Pregabalin Capsule Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Pregabalin Capsule Sales by Region (2020-2025) & (K Units)
 Table 18. Global Pregabalin Capsule Sales Market Share by Region (2020-2025)
 Table 19. Global Pregabalin Capsule Sales by Region (2026-2031) & (K Units)
 Table 20. Global Pregabalin Capsule Sales Market Share by Region (2026-2031)
 Table 21. Global Pregabalin Capsule Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Pregabalin Capsule Revenue Market Share by Region (2020-2025)
 Table 23. Global Pregabalin Capsule Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Pregabalin Capsule Revenue Market Share by Region (2026-2031)
 Table 25. North America Pregabalin Capsule Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Pregabalin Capsule Sales by Country (2020-2025) & (K Units)
 Table 27. North America Pregabalin Capsule Sales by Country (2026-2031) & (K Units)
 Table 28. North America Pregabalin Capsule Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Pregabalin Capsule Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Pregabalin Capsule Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Pregabalin Capsule Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Pregabalin Capsule Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Pregabalin Capsule Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Pregabalin Capsule Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Pregabalin Capsule Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Pregabalin Capsule Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Pregabalin Capsule Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Pregabalin Capsule Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Pregabalin Capsule Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Pregabalin Capsule Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Pregabalin Capsule Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Pregabalin Capsule Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Pregabalin Capsule Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Pregabalin Capsule Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Pregabalin Capsule Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Pregabalin Capsule Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Pregabalin Capsule Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Pregabalin Capsule Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Pregabalin Capsule Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Pregabalin Capsule Sales (K Units) by Type (2020-2025)
 Table 51. Global Pregabalin Capsule Sales (K Units) by Type (2026-2031)
 Table 52. Global Pregabalin Capsule Sales Market Share by Type (2020-2025)
 Table 53. Global Pregabalin Capsule Sales Market Share by Type (2026-2031)
 Table 54. Global Pregabalin Capsule Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Pregabalin Capsule Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Pregabalin Capsule Revenue Market Share by Type (2020-2025)
 Table 57. Global Pregabalin Capsule Revenue Market Share by Type (2026-2031)
 Table 58. Global Pregabalin Capsule Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Pregabalin Capsule Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Pregabalin Capsule Sales (K Units) by Application (2020-2025)
 Table 61. Global Pregabalin Capsule Sales (K Units) by Application (2026-2031)
 Table 62. Global Pregabalin Capsule Sales Market Share by Application (2020-2025)
 Table 63. Global Pregabalin Capsule Sales Market Share by Application (2026-2031)
 Table 64. Global Pregabalin Capsule Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Pregabalin Capsule Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Pregabalin Capsule Revenue Market Share by Application (2020-2025)
 Table 67. Global Pregabalin Capsule Revenue Market Share by Application (2026-2031)
 Table 68. Global Pregabalin Capsule Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Pregabalin Capsule Price (US$/Unit) by Application (2026-2031)
 Table 70. Actavis Pharma Company Information
 Table 71. Actavis Pharma Description and Business Overview
 Table 72. Actavis Pharma Pregabalin Capsule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Actavis Pharma Pregabalin Capsule Product
 Table 74. Actavis Pharma Recent Developments/Updates
 Table 75. Stat Rx USA Company Information
 Table 76. Stat Rx USA Description and Business Overview
 Table 77. Stat Rx USA Pregabalin Capsule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Stat Rx USA Pregabalin Capsule Product
 Table 79. Stat Rx USA Recent Developments/Updates
 Table 80. Accord Healthcare Company Information
 Table 81. Accord Healthcare Description and Business Overview
 Table 82. Accord Healthcare Pregabalin Capsule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Accord Healthcare Pregabalin Capsule Product
 Table 84. Accord Healthcare Recent Developments/Updates
 Table 85. Angita Pharma Company Information
 Table 86. Angita Pharma Description and Business Overview
 Table 87. Angita Pharma Pregabalin Capsule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Angita Pharma Pregabalin Capsule Product
 Table 89. Angita Pharma Recent Developments/Updates
 Table 90. Pfizer Company Information
 Table 91. Pfizer Description and Business Overview
 Table 92. Pfizer Pregabalin Capsule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Pfizer Pregabalin Capsule Product
 Table 94. Pfizer Recent Developments/Updates
 Table 95. Succeway Pharmaceuticals Company Information
 Table 96. Succeway Pharmaceuticals Description and Business Overview
 Table 97. Succeway Pharmaceuticals Pregabalin Capsule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Succeway Pharmaceuticals Pregabalin Capsule Product
 Table 99. Succeway Pharmaceuticals Recent Developments/Updates
 Table 100. Wan Vee Pharm Company Information
 Table 101. Wan Vee Pharm Description and Business Overview
 Table 102. Wan Vee Pharm Pregabalin Capsule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Wan Vee Pharm Pregabalin Capsule Product
 Table 104. Wan Vee Pharm Recent Developments/Updates
 Table 105. Qilu Pharmaceutical Company Information
 Table 106. Qilu Pharmaceutical Description and Business Overview
 Table 107. Qilu Pharmaceutical Pregabalin Capsule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Qilu Pharmaceutical Pregabalin Capsule Product
 Table 109. Qilu Pharmaceutical Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Pregabalin Capsule Distributors List
 Table 113. Pregabalin Capsule Customers List
 Table 114. Pregabalin Capsule Market Trends
 Table 115. Pregabalin Capsule Market Drivers
 Table 116. Pregabalin Capsule Market Challenges
 Table 117. Pregabalin Capsule Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Pregabalin Capsule
 Figure 2. Global Pregabalin Capsule Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pregabalin Capsule Market Share by Type: 2024 & 2031
 Figure 4. 25mg Capsule Product Picture
 Figure 5. 50mg Capsule Product Picture
 Figure 6. 75mg Capsule Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Pregabalin Capsule Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Pregabalin Capsule Market Share by Application: 2024 & 2031
 Figure 10. Clinics
 Figure 11. Hospitals
 Figure 12. Others
 Figure 13. Global Pregabalin Capsule Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Pregabalin Capsule Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Pregabalin Capsule Sales (2020-2031) & (K Units)
 Figure 16. Global Pregabalin Capsule Average Price (US$/Unit) & (2020-2031)
 Figure 17. Pregabalin Capsule Report Years Considered
 Figure 18. Pregabalin Capsule Sales Share by Manufacturers in 2024
 Figure 19. Global Pregabalin Capsule Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Pregabalin Capsule Players: Market Share by Revenue in Pregabalin Capsule in 2024
 Figure 21. Pregabalin Capsule Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Pregabalin Capsule Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Pregabalin Capsule Sales Market Share by Country (2020-2031)
 Figure 24. North America Pregabalin Capsule Revenue Market Share by Country (2020-2031)
 Figure 25. United States Pregabalin Capsule Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Pregabalin Capsule Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Pregabalin Capsule Sales Market Share by Country (2020-2031)
 Figure 28. Europe Pregabalin Capsule Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Pregabalin Capsule Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Pregabalin Capsule Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Pregabalin Capsule Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Pregabalin Capsule Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Pregabalin Capsule Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Pregabalin Capsule Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Pregabalin Capsule Revenue Market Share by Region (2020-2031)
 Figure 36. China Pregabalin Capsule Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Pregabalin Capsule Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Pregabalin Capsule Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Pregabalin Capsule Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Pregabalin Capsule Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Pregabalin Capsule Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Southeast Asia Pregabalin Capsule Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Pregabalin Capsule Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Pregabalin Capsule Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Pregabalin Capsule Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Pregabalin Capsule Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Pregabalin Capsule Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Pregabalin Capsule Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Pregabalin Capsule Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Pregabalin Capsule Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Pregabalin Capsule Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Pregabalin Capsule Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Pregabalin Capsule by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Pregabalin Capsule by Type (2020-2031)
 Figure 55. Global Pregabalin Capsule Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Pregabalin Capsule by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Pregabalin Capsule by Application (2020-2031)
 Figure 58. Global Pregabalin Capsule Price (US$/Unit) by Application (2020-2031)
 Figure 59. Pregabalin Capsule Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD